The results of this study demonstrate that ceftizoxime, a new β-lactamase-stable cephalosporin is as effective as cefamandole for eradicating susceptible pathogens from the urine of adult females with a clinical diagnosis of pyelonephritis. The effective daily dosage of ceftizoxime in this study was half that of cefamandole. There was no difference in the observed incidence of adverse drug reactions to each agent.
|Original language||English (US)|
|Number of pages||103|
|Journal||Journal of Antimicrobial Chemotherapy|
|Issue number||Suppl. C|
|State||Published - 1982|
ASJC Scopus subject areas